Bliss GVS Pharma Income Statement

Quarterly

Yearly

home icon
The current prices are delayed, login to your account to see live prices.
LOGIN
202120222023
EBITDA129150135
EBIT11159116
Earning Per Share617
Expenses471629634
Net Profit742377
Net Profit Margin13310
Operating Profit Margin222018
Profit Before Tax10454106
Dividends Per Share111
Operation Revenue597779769

Peer Comparison (in ₹.Cr.)

CompanyYearEBITEBITDANet ProfitNet WorthProfit Before Tax
20230080.62NA86.80
20221,739.202,486.90993.609,042.131,441.20
202300447.69NA716.49
2023004,470.30NA6,011.50
2023008,560.84NA9,408.43
The EBITDA of Bliss GVS Pharma is 135 as of 2/27/2024
home icon
The current prices are delayed, login to your account to see live prices.
LOGIN
20182019202020212023
Operating Activities1840476434
Investing Activities50-74-48-47-8
Financing Activities-7617-6-21-25
Others00000
Net Cash Flow-8-17-7-42

Peer Comparison (in ₹.Cr.)

CompanyYearOperating ActivitiesInvesting ActivitiesFinancing ActivitiesNet Cash Flow
2021-2.18-34.87-15.36-52.41
2023625.39-528.49-77.4619.45
20201,468.841,106.99-890.581,685.25
20235,887.50-4,137.30-2,686.10-935.90
20234,959.33-7,943.682,376.07-608.28
The cash flow from Operating Activities of Bliss GVS Pharma is 34 as of 2/27/2024